---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-022913"
form_type: "8-K"
ticker: "COCH"
cik: "0001840877"
company_name: "Envoy Medical, Inc."
filed_at: "2025-03-12T23:59:59+00:00"
generated_at: "2026-05-24T22:43:13.298351+00:00"
event_type: "debt"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Envoy Medical obtains $10M promissory note from largest shareholder Glen Taylor

## Summary
- Initial $5M funded on March 11, 2025; up to $10M available in $2.5M tranches over 2 years.
- 8.0% interest rate, deferred and compounding for first 2 years; 5-year term matures March 6, 2030.
- Commitment fee: 375,000 warrants per $2.5M tranche; initial 750,000 warrants at $1.35/share exercise price.
- Funds will support Acclaim cochlear implant pivotal clinical trial and general operations.
- Glen Taylor is board member and controlling stockholder; facility unsecured with no conversion feature.

## SEC filing metadata
- accession: 0001213900-25-022913
- form_type: 8-K
- ticker: COCH
- cik: 0001840877
- company_name: Envoy Medical, Inc.
- filed_at: 2025-03-12T23:59:59+00:00
- event_type: debt
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840877/000121390025022913/0001213900-25-022913-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840877/000121390025022913/ea0234061-8k_envoy.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-022913
- JSON: https://secwatch.observer/filing/0001213900-25-022913.json
- Plain text: https://secwatch.observer/filing/0001213900-25-022913.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.